For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
System Fix: Episode 16 - And that was 2021
This item is over 2 years old; some content may no longer be current
FREE READ
+News
PODCAST - FREE READ
System Fix: Episode 16 - And that was 2021
Friday 17 December 2021, 01:22 PM
21 minutes to Listen

It's been a few weeks between episodes while the sector has been responding to COVID matters. As our office closes for 2021, I thought it was worthwhile squeezing in a final episode of System Fix for the year. I grabbed senior journalist Martin Johnston and asked for a recap of the year in health reform
FREE and EASY
We're publishing this article as a FREE READ so it is Free to read and Easy to share more widely. Please support us and our journalism – subscribe here